Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service
"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS
Ergebnis verändern
-
1
von Kirschner, Matthias ; Hodzic-Santor, Benazir ; Kennedy, Leda ; et al.
Molecular Psychiatry. :1-15
-
2
von Ciampelli, Silvia ; de Boer, Janna Niña ; Voppel, Alban Elias ; et al.
Schizophrenia. 11(1)
-
3
von Sommer, Iris ; de Haan, Lieuwe ; Veling, Wim ; et al.
In European Neuropsychopharmacology April 2026 105
-
4
von Liu,Yinzhao ; Sommer, Iris E ; Schoretsanitis,Georgios ; et al.
Schlagworte: Therapeutic drug monitoring; Antipsychotic agents; Metabolic syndrome; Extrapyramidal side effects; Pharmacology; Neurology; Clinical Neurology; Psychiatry and Mental health; Biological Psychiatry; Pharmacology (medical); Journal Article
-
5
von Oomen, Priscilla P. ; Gangadin,Shiral S. ; de Haan,Lieuwe ; et al.
Schlagworte: antipsychotic medication; cognition; dopamine D2 affinity; psychosis; schizophrenia; Applied Psychology; Psychiatry and Mental health
-
6
von Sommer, Iris E. ; de Beer,Franciska ; Gangadin,Shiral ; et al.
Schlagworte: Psychiatry and Mental health
-
7
von Oomen, Priscilla P. ; Gangadin, Shiral S. ; de Haan, Lieuwe ; et al.
Oomen, P P, Gangadin, S S, de Haan, L, de Beer, F, Beune, O E, Oostendorp, D A D, Begemann, M J H, Boonstra, N, Kikkert, M, Koops, S, Veling, W & Sommer, I E C 2026, 'Negative association between cognitive functioning and antipsychotic D 2 receptor occupancy, affinity, and dose after first episode psychosis', Psychological Medicine, vol. 56. https://doi.org/10.1017/S0033291725102900
Schlagworte: antipsychotic medication; cognition; dopamine D2 affinity; psychosis; schizophrenia
- 8
-
9
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
-
10
von de Boer, Janna N. ; Ciampelli, Silvia ; Hailemariam, Araya K. ; et al.
NPP—Digital Psychiatry and Neuroscience. 4(1)
- 11
-
12
von Silva, Ana I. ; Sønderby, Ida E. ; Kirov, George ; et al.
In Biological Psychiatry: Cognitive Neuroscience and Neuroimaging May 2025
-
13
von Djordjevic, Matej ; Jongsma, Hannah E. ; Simons, Claudia J.P. ; et al.
In Journal of Psychiatric Research January 2025 181:560-569
-
14
von de Beer, Franciska ; Wijnen, Ben ; Wouda, Lotte ; et al.
In Schizophrenia Research December 2024 274:299-306
-
15
von Maas, Isolde L. ; Bohlken, Marc M. ; Gangadin, Shiral S. ; et al.
In Schizophrenia Research April 2024 266:32-40
-
16
von Agartz, Ingrid ; Asherson, Philip ; Ayesa-Arriola, Rosa ; et al.
In The Lancet Digital Health March 2024 6(3):e211-e221
-
17
von Marschall, Theresa M. ; Brederoo, Sanne G. ; Koops, Sanne ; et al.
Scientific Reports. 14(1)
-
18
von de Beer,Franciska ; de Vries,Erik ; Wijnen,Ben ; et al.
Schlagworte: Adult; Antipsychotic Agents/therapeutic use; Case-Control Studies; Corpus Striatum/metabolism; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Positron-Emission Tomography; Psychotic Disorders/drug therapy; Raclopride; Receptors; Dopamine D2/metabolism; Dopamine D3/metabolism; Recurrence; Young Adult; Journal Article
-
19
von Hidding,Marit ; Van Der Stouwe,Elise ; Rosema,Bram Sieben ; et al.
Schlagworte: antipsychotic medication; first-episode psychosis; negative side effects; recovery; self-esteem; Applied Psychology; Psychiatry and Mental health
-
20
von Djordjevic,Matej ; Jongsma,Hannah E. ; Simons,Claudia J.P. ; et al.
Schlagworte: Early psychosis; Ecological momentary assessment; Experience sampling method; First episode psychosis; Schizophrenia spectrum disorders; Social functioning; Psychiatry and Mental health; Biological Psychiatry; Journal Article
-
21
von Gangadin,Shiral S. ; de Beer,Franciska ; Wijnen,Ben ; et al.
Schlagworte: Antipsychotic medication; D2 receptor affinity; dopamine supersensitivity; dose reduction; first episode psychosis; partial D2 agonists; relapse; tapering; Taverne; Phychiatric Mental Health; Psychiatry and Mental health; Journal Article
-
22
von Liu, Yinzhao ; Sommer, Iris E. ; Begemann, Marieke J. H. ; et al.
Liu, Y, Sommer, I E, Begemann, M J H, Gangadin, S S, Perry, B, Scheurink, T A W, van Beveren, N J M, Bakker, P R, Koops, S & HAMLETT and OPHELIA Consortium 2025, 'The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis', Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf116
Schlagworte: antipsychotic agents; dose dependency; metabolic disturbances; extrapyramidal side effects; EXTRAPYRAMIDAL SYNDROMES; SCHIZOAFFECTIVE DISORDER; RATING-SCALE; SCHIZOPHRENIA; DRUGS; MANAGEMENT; RISK; EQUIVALENTS; RECEPTORS; SYMPTOMS
-
23
von Ciampelli, Silvia ; de Boer, Janna ; Koops, Sanne ; et al.
Ciampelli, S, de Boer, J, Koops, S, Voppel, A, Corona Hernandez, H, Oldehinkel, A & Sommer, I 2025, 'Cross-sectional and longitudinal associations between anxiety and acoustic-prosodic markers in adolescents', Psychological Medicine, vol. 55, e322. https://doi.org/10.1017/S0033291725102274
Schlagworte: adolescents; anxiety disorders classification; machine learning; predictive modelling; speech markers
-
24
von de Beer, Franciska ; de Vries, Erik ; Wijnen, Ben ; et al.
de Beer, F, de Vries, E, Wijnen, B, Begemann, M J H, van Beveren, N, Boonstra, N, Gangadin, S S, de Haan, L, Hamers, I M H, Veling, W, Koops, S & Sommer, I E C 2025, 'Dopamine D2/3R availability after discontinuation of antipsychotic treatment : a [11C]raclopride PET study in remitted first-episode psychosis patients.', Psychological Medicine, vol. 55, e264. https://doi.org/10.1017/S003329172510161X
Schlagworte: Humans; Positron-Emission Tomography; Male; Antipsychotic Agents/therapeutic use; Female; Adult; Raclopride; Psychotic Disorders/drug therapy; Receptors; Dopamine D2/metabolism; Dopamine D3/metabolism; Young Adult; Recurrence; Dopamine D2 Receptor Antagonists; Corpus Striatum/metabolism; Case-Control Studies
-
25
von Liu, Yinzhao ; Sommer, Iris E. ; Schoretsanitis, Georgios ; et al.
Liu, Y, Sommer, I E, Schoretsanitis, G, Hamers, I, Scheurink, T, Begemann, M, Gangadin, S, van Beveren, N J M, Sommer, I, de Haan, L, Veling, W, van Os, J, Smit, F, Begemann, M, Koops, S, Marcelis, M, Kikkert, M, van Beveren, N, Boonstra, N, Rosema, B S, Bakker, P R, Gülöksüz, S, Lokkerbol, J, Wijnen, B, Brand, B, Gangadin, S, Erna van ’t, H, Oomen, P, Voppel, A, de Beer, F, Kamphuis, S, Hamers, I, Djordjevic, M, Scheurink, T, Noorman, J, van Amelsvoort, T, Bak, M, Berendsen, S, van den Brink, T, Faber, G, Grootens, K, de Jonge, M, Knegtering, H, Kurkamp, J, Pijnenborg, G H M, Staring, A, Veen, N, Veerman, S, Wiersma, S, Batalla, A, Curfs, R, Hage, J J, Graveland, E, Hoornaar, J, Hobus, I, Huizer, K, Koops, S & Bakker, P R 2026, 'Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects : A comparison with prescription dose', European Neuropsychopharmacology, vol. 105, 112769.
Schlagworte: dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being; info:eu-repo/semantics/article; info:eu-repo/semantics/publishedVersion
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag

Publikationstyp